Holen Sie sich die Stockscreener-App
56.85
1.94%
1.15
Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten
Statistical indicators supporting Supernus Pharmaceuticals Inc.’s strengthDollar Strength & High Return Stock Watch Alerts - newser.com
Is Supernus Pharmaceuticals Inc. a candidate for recovery play2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Top chart patterns to watch in Supernus Pharmaceuticals Inc.Stop Loss & Weekly Top Stock Performers List - newser.com
Why Supernus Pharmaceuticals Inc. stock remains undervaluedWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Can Supernus Pharmaceuticals Inc. stock continue upward trendJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
Supernus Pharmaceuticals Inc. stock trendline breakdownEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
Using data models to predict Supernus Pharmaceuticals Inc. stock movementBuy Signal & Verified Short-Term Plans - newser.com
Long term hold vs stop loss in Supernus Pharmaceuticals Inc.Bear Alert & Technical Analysis for Trade Confirmation - newser.com
Supernus Pharmaceuticals (SUPN) Reports Q3: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - MSN
Is Supernus Pharmaceuticals Inc. stock near bottom after declineEntry Point & Stepwise Trade Signal Implementation - newser.com
Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.2025 Support & Resistance & Verified Short-Term Trading Plans - newser.com
Is Supernus Pharmaceuticals Inc. stock attractive after correctionJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com
How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsRisk Management & Smart Swing Trading Techniques - newser.com
Supernus Pharmaceuticals Advances ADHD Treatment Study in Young Children - MSN
What institutional flow reveals about Supernus Pharmaceuticals Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
Supernus Pharmaceuticals Inc expected to post earnings of 28 cents a shareEarnings Preview - TradingView
Supernus Pharmaceuticals (SUPN): Is the Recent Rally Reflected in Its Valuation? - Sahm
Supernus Pharmaceuticals Hits New 52-Week High of $57.65 - Markets Mojo
Supernus a new buy at BofA on 'underappreciated' CNS assets - MSN
How Supernus Pharmaceuticals Inc. stock reacts to Fed rate cutsPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
Sentiment analysis tools applied to Supernus Pharmaceuticals Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - newser.com
Supernus Pharmaceuticals, Inc. (SUPN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Supernus Pharmaceuticals Hits New 52-Week High of $55.95 - Markets Mojo
Supernus Pharmaceuticals (SUPN) Price Target Increased by 32.88% to 59.36 - MSN
Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts - Yahoo! Finance UK
Supernus Pharmaceuticals Inc Stock Analysis and ForecastQuarterly Earnings Review & Rapid Portfolio Appreciation - earlytimes.in
Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts - Yahoo! Finance Canada
Supernus Pharmaceuticals (SUPN) Gains Market Attention with Key CNS Drugs - GuruFocus
Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy - sharewise.com
Can Supernus Pharmaceuticals Sustain Momentum After 13% Jump on Neuroscience Pipeline News? - Yahoo Finance
Supernus Pharmaceuticals Hits New 52-Week High of $53.28 - Markets Mojo
BofA Securities Initiates Supernus Pharmaceuticals at Buy With $65 Price Target - MarketScreener
B of A Securities Initiates Coverage on SUPN with a Buy Rating | - GuruFocus
0.41%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):